| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 24.430 | 0 | 0 |
| Total Income - EUR | 173 | 98 | 28 | 85 | 38 | 16 | 12.593 | 24.472 | 28 | 30 |
| Total Expenses - EUR | 2.429 | 2.039 | 2.102 | 1.709 | 4.615 | 3.233 | 7.880 | 9.984 | 12.399 | 15.591 |
| Gross Profit/Loss - EUR | -2.256 | -1.941 | -2.074 | -1.624 | -4.577 | -3.216 | 4.713 | 14.488 | -12.371 | -15.561 |
| Net Profit/Loss - EUR | -2.256 | -1.942 | -2.074 | -1.625 | -4.577 | -3.216 | 4.343 | 13.770 | -12.371 | -15.561 |
| Employees | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Biomed - Khaled Khalil Limited Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 8.176 | 8.093 | 7.956 | 7.810 | 7.659 | 7.514 | 0 | 0 | 0 | 0 |
| Current Assets | 224.609 | 217.924 | 210.369 | 204.881 | 200.665 | 194.437 | 249.905 | 245.754 | 174.485 | 156.771 |
| Inventories | 207.017 | 204.928 | 201.461 | 197.763 | 193.933 | 190.257 | 186.038 | 179.372 | 134.304 | 124.218 |
| Receivables | 5.559 | 6.645 | 5.515 | 5.628 | 5.628 | 3.228 | 689 | 23.885 | 22.569 | 25.320 |
| Cash | 12.034 | 6.351 | 3.393 | 1.489 | 1.103 | 952 | 63.179 | 42.497 | 17.612 | 7.233 |
| Shareholders Funds | 58.229 | 55.686 | 52.670 | 50.078 | 44.530 | 40.470 | 11.471 | 13.867 | -56.799 | -72.042 |
| Social Capital | 98 | 89 | 88 | 86 | 84 | 83 | 81 | 81 | 81 | 80 |
| Debts | 174.556 | 170.331 | 165.655 | 162.614 | 163.793 | 161.480 | 238.434 | 231.887 | 231.284 | 228.814 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6810 - 6810" | |||||||||
| CAEN Financial Year |
6810
|
|||||||||
Comments - Biomed - Khaled Khalil Limited Srl